CMS Finalizes Reforms to Skin Substitute Payments: Implications for Providers and Value-Based Care
The Centers for Medicare & Medicaid Services (CMS) has finalized comprehensive changes to Medicare reimbursement for skin substitute products used in wound care. Effective January 1, 2026, the rule restructures Medicare Part B payment methodology across hospital outpatient and non-facility settings, shifting away from the traditional average sales price (ASP) model toward a standardized flat-rate […]



















